Swiss eyecare giant Alcon has made a new offer for Staar Surgical worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal despite opposition from Staar's biggest shareholder.

The latest offer is worth $30.75 per share in cash. Alcon has also reduced the level of related payments to Staar executives should the deal go through. Those payments had aso been criticised by Staar's top shareholder, Broadwood Partners .

Alcon's original offer, agreed in early August, was worth $28 per share and valued the company at $1.5 billion.

Staar recommended its shareholders vote in favour of the latest deal in a meeting on December 19. The transaction is expected to close in early 2026, Alcon said.

The vote had previously been

postponed three times.

Broadwood declined to comment

See Full Page